ELEVANCE HEALTH INC (A58.DE) Fundamental Analysis & Valuation

FRA:A58 • US0367521038

Current stock price

271.9 EUR
+5.5 (+2.06%)
Last:

This A58.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. A58.DE Profitability Analysis

1.1 Basic Checks

  • In the past year A58 was profitable.
  • A58 had a positive operating cash flow in the past year.
  • Each year in the past 5 years A58 has been profitable.
  • Each year in the past 5 years A58 had a positive operating cash flow.
A58.DE Yearly Net Income VS EBIT VS OCF VS FCFA58.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • With an excellent Return On Assets value of 4.17%, A58 belongs to the best of the industry, outperforming 82.14% of the companies in the same industry.
  • With a decent Return On Equity value of 11.94%, A58 is doing good in the industry, outperforming 78.57% of the companies in the same industry.
  • A58's Return On Invested Capital of 5.16% is in line compared to the rest of the industry. A58 outperforms 53.57% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for A58 is in line with the industry average of 5.74%.
Industry RankSector Rank
ROA 4.17%
ROE 11.94%
ROIC 5.16%
ROA(3y)5.09%
ROA(5y)5.45%
ROE(3y)14.2%
ROE(5y)15.16%
ROIC(3y)6.74%
ROIC(5y)7.11%
A58.DE Yearly ROA, ROE, ROICA58.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • A58's Profit Margin of 2.62% is in line compared to the rest of the industry. A58 outperforms 50.00% of its industry peers.
  • A58's Profit Margin has declined in the last couple of years.
  • A58 has a Operating Margin (3.81%) which is comparable to the rest of the industry.
  • A58's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.81%
PM (TTM) 2.62%
GM N/A
OM growth 3Y-9.09%
OM growth 5Y-8.43%
PM growth 3Y-8.92%
PM growth 5Y-5.39%
GM growth 3YN/A
GM growth 5YN/A
A58.DE Yearly Profit, Operating, Gross MarginsA58.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. A58.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so A58 is destroying value.
  • A58 has less shares outstanding than it did 1 year ago.
  • A58 has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for A58 has been reduced compared to a year ago.
A58.DE Yearly Shares OutstandingA58.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
A58.DE Yearly Total Debt VS Total AssetsA58.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • A58 has a debt to FCF ratio of 4.94. This is a neutral value as A58 would need 4.94 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 4.94, A58 is doing good in the industry, outperforming 75.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.72 indicates that A58 is somewhat dependend on debt financing.
  • The Debt to Equity ratio of A58 (0.72) is better than 60.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 4.94
Altman-Z N/A
ROIC/WACC0.62
WACC8.31%
A58.DE Yearly LT Debt VS Equity VS FCFA58.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
A58.DE Yearly Current Assets VS Current LiabilitesA58.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. A58.DE Growth Analysis

3.1 Past

  • A58 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.26%.
  • Measured over the past 5 years, A58 shows a small growth in Earnings Per Share. The EPS has been growing by 6.12% on average per year.
  • A58 shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.44%.
  • Measured over the past years, A58 shows a quite strong growth in Revenue. The Revenue has been growing by 10.32% on average per year.
EPS 1Y (TTM)-10.26%
EPS 3Y1.27%
EPS 5Y6.12%
EPS Q2Q%5.1%
Revenue 1Y (TTM)9.44%
Revenue growth 3Y8.34%
Revenue growth 5Y10.32%
Sales Q2Q%1.49%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.68% on average over the next years. This is quite good.
  • Based on estimates for the next years, A58 will show a small growth in Revenue. The Revenue will grow by 2.68% on average per year.
EPS Next Y-13.25%
EPS Next 2Y-1.04%
EPS Next 3Y4.72%
EPS Next 5Y8.68%
Revenue Next Year-2.7%
Revenue Next 2Y0.14%
Revenue Next 3Y1.81%
Revenue Next 5Y2.68%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
A58.DE Yearly Revenue VS EstimatesA58.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50B 100B 150B 200B
A58.DE Yearly EPS VS EstimatesA58.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20 40 60

More info and screens

Find the best growth stocksShow best growing peers

5

4. A58.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • A58 is valuated reasonably with a Price/Earnings ratio of 10.35.
  • A58's Price/Earnings ratio is rather cheap when compared to the industry. A58 is cheaper than 82.14% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.64, A58 is valued rather cheaply.
  • A Price/Forward Earnings ratio of 10.78 indicates a reasonable valuation of A58.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of A58 indicates a somewhat cheap valuation: A58 is cheaper than 78.57% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 21.36, A58 is valued a bit cheaper.
Industry RankSector Rank
PE 10.35
Fwd PE 10.78
A58.DE Price Earnings VS Forward Price EarningsA58.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as A58.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of A58 is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 10.85
EV/EBITDA 9.98
A58.DE Per share dataA58.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.69
EPS Next 2Y-1.04%
EPS Next 3Y4.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. A58.DE Dividend Analysis

5.1 Amount

  • A58 has a Yearly Dividend Yield of 1.99%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 1.69, A58 has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.80, A58 has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.99%

5.2 History

  • The dividend of A58 is nicely growing with an annual growth rate of 12.23%!
Dividend Growth(5Y)12.23%
Div Incr Years0
Div Non Decr Years0
A58.DE Yearly Dividends per shareA58.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2025 2026 1 2 3 4 5

5.3 Sustainability

  • 28.97% of the earnings are spent on dividend by A58. This is a low number and sustainable payout ratio.
  • The dividend of A58 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.97%
EPS Next 2Y-1.04%
EPS Next 3Y4.72%
A58.DE Yearly Income VS Free CF VS DividendA58.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B
A58.DE Dividend Payout.A58.DE Dividend Payout, showing the Payout Ratio.A58.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

A58.DE Fundamentals: All Metrics, Ratios and Statistics

ELEVANCE HEALTH INC

FRA:A58 (4/17/2026, 7:00:00 PM)

271.9

+5.5 (+2.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength40.37
Industry Growth70.81
Earnings (Last)04-22
Earnings (Next)07-15
Inst Owners93.83%
Inst Owner ChangeN/A
Ins Owners0.15%
Ins Owner ChangeN/A
Market Cap59.73B
Revenue(TTM)200.41B
Net Income(TTM)5.24B
Analysts74.29
Price Target327.99 (20.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.99%
Yearly Dividend5.83
Dividend Growth(5Y)12.23%
DP28.97%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.97%
Min EPS beat(2)6.46%
Max EPS beat(2)15.49%
EPS beat(4)3
Avg EPS beat(4)10.18%
Min EPS beat(4)-2.26%
Max EPS beat(4)21.02%
EPS beat(8)6
Avg EPS beat(8)3.86%
EPS beat(12)9
Avg EPS beat(12)3.06%
EPS beat(16)12
Avg EPS beat(16)2.8%
Revenue beat(2)1
Avg Revenue beat(2)-0.27%
Min Revenue beat(2)-2%
Max Revenue beat(2)1.45%
Revenue beat(4)3
Avg Revenue beat(4)0.34%
Min Revenue beat(4)-2%
Max Revenue beat(4)1.45%
Revenue beat(8)7
Avg Revenue beat(8)1.17%
Revenue beat(12)9
Avg Revenue beat(12)1.04%
Revenue beat(16)12
Avg Revenue beat(16)0.99%
PT rev (1m)-3.14%
PT rev (3m)-3.39%
EPS NQ rev (1m)-0.62%
EPS NQ rev (3m)-18.72%
EPS NY rev (1m)0.07%
EPS NY rev (3m)-3.89%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-6.15%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-5.81%
Valuation
Industry RankSector Rank
PE 10.35
Fwd PE 10.78
P/S 0.35
P/FCF 10.85
P/OCF 9.2
P/B 1.59
P/tB 15.65
EV/EBITDA 9.98
EPS(TTM)26.28
EY9.67%
EPS(NY)25.23
Fwd EY9.28%
FCF(TTM)25.07
FCFY9.22%
OCF(TTM)29.56
OCFY10.87%
SpS779.02
BVpS170.65
TBVpS17.37
PEG (NY)N/A
PEG (5Y)1.69
Graham Number317.655 (16.83%)
Profitability
Industry RankSector Rank
ROA 4.17%
ROE 11.94%
ROCE 6.49%
ROIC 5.16%
ROICexc 5.62%
ROICexgc 10.13%
OM 3.81%
PM (TTM) 2.62%
GM N/A
FCFM 3.22%
ROA(3y)5.09%
ROA(5y)5.45%
ROE(3y)14.2%
ROE(5y)15.16%
ROIC(3y)6.74%
ROIC(5y)7.11%
ROICexc(3y)7.29%
ROICexc(5y)7.65%
ROICexgc(3y)13.44%
ROICexgc(5y)14.29%
ROCE(3y)8.45%
ROCE(5y)8.91%
ROICexgc growth 3Y-7.91%
ROICexgc growth 5Y-6.83%
ROICexc growth 3Y-6.71%
ROICexc growth 5Y-5.47%
OM growth 3Y-9.09%
OM growth 5Y-8.43%
PM growth 3Y-8.92%
PM growth 5Y-5.39%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.59
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 4.94
Debt/EBITDA 3.44
Cap/Depr 75.64%
Cap/Sales 0.58%
Interest Coverage 250
Cash Conversion 83.03%
Profit Quality 123.02%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC8.31%
ROIC/WACC0.62
Cap/Depr(3y)78.87%
Cap/Depr(5y)77.78%
Cap/Sales(3y)0.68%
Cap/Sales(5y)0.71%
Profit Quality(3y)81.36%
Profit Quality(5y)97.25%
High Growth Momentum
Growth
EPS 1Y (TTM)-10.26%
EPS 3Y1.27%
EPS 5Y6.12%
EPS Q2Q%5.1%
EPS Next Y-13.25%
EPS Next 2Y-1.04%
EPS Next 3Y4.72%
EPS Next 5Y8.68%
Revenue 1Y (TTM)9.44%
Revenue growth 3Y8.34%
Revenue growth 5Y10.32%
Sales Q2Q%1.49%
Revenue Next Year-2.7%
Revenue Next 2Y0.14%
Revenue Next 3Y1.81%
Revenue Next 5Y2.68%
EBIT growth 1Y-16.07%
EBIT growth 3Y-1.51%
EBIT growth 5Y1.02%
EBIT Next Year-1.32%
EBIT Next 3Y5.18%
EBIT Next 5Y7.75%
FCF growth 1Y180.92%
FCF growth 3Y-24.06%
FCF growth 5Y-19.97%
OCF growth 1Y113.03%
OCF growth 3Y-20.06%
OCF growth 5Y-16.69%

ELEVANCE HEALTH INC / A58.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ELEVANCE HEALTH INC?

ChartMill assigns a fundamental rating of 4 / 10 to A58.DE.


What is the valuation status of ELEVANCE HEALTH INC (A58.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to ELEVANCE HEALTH INC (A58.DE). This can be considered as Fairly Valued.


How profitable is ELEVANCE HEALTH INC (A58.DE) stock?

ELEVANCE HEALTH INC (A58.DE) has a profitability rating of 4 / 10.


What is the financial health of ELEVANCE HEALTH INC (A58.DE) stock?

The financial health rating of ELEVANCE HEALTH INC (A58.DE) is 3 / 10.


Can you provide the expected EPS growth for A58 stock?

The Earnings per Share (EPS) of ELEVANCE HEALTH INC (A58.DE) is expected to decline by -13.25% in the next year.